Alignment Healthcare, Inc.

Listed Company

ALHCCIK 0001832466NasdaqLarge AcceleratedHospital & Medical Service PlansDelawareFY ends Dec 31

Period

FY 2024

Revenue

$2.70B

Net Income

$-128.03M

Total Assets

$782.06M

Equity

$99.85M

Shares Out

206.73M

Op. Cash Flow

$34.77M

Business

Alignment Healthcare provides Medicare Advantage health plans and integrated care management focused on seniors, aiming to coordinate clinical and insurance services to improve outcomes. It offers products and services including Medicare Advantage HMO and PPO plans, a proprietary AVA data and analytics platform, in-house Care Anywhere clinical teams, concierge member services, digital member portals and supplemental benefits. Its key business components comprise health plan operations, technology and analytics, in-house clinical delivery (Care Anywhere), provider partnerships and growth/sales operations. The company distributes plans across multiple U.S. markets and states through direct CMS contracts, brokers and digital direct-to-consumer channels.

Summary from filing dated 2025-02-27

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31
Earned premiums	2,672	1,801	1,432	1,167	955
Other	32	23	3	—	—
Total revenues	2,704	1,824	1,434	1,168	959
Medical expenses	2,407	1,623	1,250	1,039	793
Selling, general, and administrative expenses	371	307	296	291	156
Depreciation and amortization	27	21	17	16	15
Total expenses	2,805	1,951	1,563	1,346	964
Loss from operations	−102	−128	−129	−178	−5
Interest expense	24	21	18	—	—
Other (income) expenses, net	−72,000	−853,000	176,000	17	18
Loss on extinguishment of debt	3	0	2	0	0
Total other expenses	26	20	21	—	—
Loss before income taxes	−128	−148	−149	−195	−23
Net income tax expense (benefit)	21,000	−22,000	339,000	0	0
Net loss	−128	−148	−150	−195	−23
Less: Net loss attributable to noncontrolling interest	36,000	156,000	92,000	0	0
Net loss attributable to Alignment Healthcare, Inc.	−128	−148	−150	−195	−23
Total weighted-average common shares outstanding - basic (in shares)	191	186	181	—	—
Total weighted-average common shares outstanding - diluted (in shares)	191	186	181	—	—
Net loss per share attributable to Alignment Healthcare, Inc. - basic (in dollars per share)	−0.67	−0.79	−0.83	−1.14	−0.15
Net loss per share attributable to Alignment Healthcare, Inc. - diluted (in dollars per share)	−0.67	−0.79	−0.83	−1.14	−0.15

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31
Cash and cash equivalents	433	203	410	467	—
Accounts receivable (less allowance for credit losses of $0 at December 31, 2024 and 2023)	154	120	93	59	40
Investments - current	38	116	0	—	—
Prepaid expenses and other current assets	37	45	42	28	17
Total current assets	662	484	545	553	265
Property and equipment, net	67	52	37	30	27
Right of use asset, net	8	10	—	—	—
Goodwill	35	35	35	—	—
Intangible Assets, net	5	5	5	—	—
Other assets	6	6	6	5	2
Total assets	782	592	634	631	339
Medical expenses payable	290	205	170	126	113
Accounts payable and accrued expenses	22	24	32	17	16
Accrued compensation	40	34	—	—	—
Total current liabilities	352	263	230	167	153
Long-term debt, net of debt issuance costs	321	162	161	151	144
Long-term portion of lease liabilities	8	9	—	—	—
Total liabilities	681	434	395	325	308
Commitments and Contingencies (Note 14)	—	—	—	—	—
Preferred stock, $.001 par value; 100,000,000 shares authorized as of December 31, 2024 and 2023, respectively; no shares issued and outstanding as of December 31, 2024 and 2023	0	0	0	0	0
Common stock, $.001 par value; 1,000,000,000 shares authorized as of December 31, 2024 and December 31, 2023; 191,778,639 and 188,951,643 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively	192,000	189,000	187,000	187,000	164,000
Additional paid-in capital	1,108	1,037	970	889	410
Accumulated deficit	−1,008	−880	−732	−583	−380
Total Alignment Healthcare, Inc. stockholders' equity	100	157	238	306	31
Noncontrolling interest	1	1	1	15,000	0
Total stockholders' equity	101	158	239	306	31
Total liabilities and stockholders' equity	782	592	634	631	339

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31
Provision for credit loss	123,000	91,000	150,000	111,000	118,000
(Gain) loss on right of use assets	143,000	−289,000	510,000	—	—
Gain on sale of property and equipment	−9,000	0	0	—	—
Depreciation and amortization	27	22	17	16	15
Amortization-debt issuance costs	1	1	2	2	2
Amortization-investment discount	−3	−5	0	—	—
Amortization of payment-in-kind interest	0	0	3	4	4
Loss on disposal of property and equipment	0	0	101,000	0	1
Equity-based compensation	71	67	82	—	—
Non-cash lease expense	2	2	3	—	—
Accounts receivable	−34	−27	−34	−18	−5
Prepaid expenses and other current assets	8	−3	−14	−10	−12
Other assets	60,000	−142,000	−86,000	644,000	3
Medical expenses payable	84	35	44	13	6
Accounts payable and accrued expenses	−1	−6	14	437,000	645,000
Accrued compensation	6	7	4	—	—
Lease liabilities	−2	−4	−4	−4	1
Payment-in-kind interest	0	0	−14	0	0
Net cash provided by (used in) operating activities	35	−59	−45	−79	8
Purchase of business, net of cash received	0	0	−4	0	0
Purchase of investments	−82	−379	−3	−2	−2
Sale of property and equipment	14,000	0	0	0	100,000
Maturities of investments	163	268	2	—	—
Acquisition of property and equipment	−41	−36	−24	—	—
Net cash provided by (used in) investing activities	39	−147	−28	−21	−16
Repurchase of noncontrolling interest	0	0	−100,000	0	0
Proceeds from long-term debt	380	0	165	0	0
Debt issuance costs	−9	0	−5	0	0
Repayment of long-term debt	−215	0	−143	0	0
Payment of employment taxes related to release of restricted stock	−350,000	0	0	—	—
Proceeds from exercise of stock options	155,000	0	0	—	—
Contributions from noncontrolling interest holders	15,000	105,000	68,000	15,000	0
Net cash provided by financing activities	156	105,000	17	360	130
Net increase (decrease) in cash	230	−206	−57	—	—
Cash paid for interest	22	19	22	11	11
Acquisition of property in accounts payable	70,000	59,000	47,000	0	0
Purchase of business in accounts payable	0	0	505,000	—	—
Debt issuance costs in accounts payable	512,000	0	0	—	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro